Thought we’d get a Q after hours. Fuse is a little late filing their Q, or maybe it’s a K, also. Generex also said in the CC 7-10 days they hoped for news on the direct to patient pharmacy, so this week’s late news can be next week’s new news. I think the main item investors need to hear involves the bank funding Joe mentioned. Twice we heard of lines of credit, which (neither version) didn’t materialize, then the bank funding, so that needs to be formalized in a 8k to give investors better or smart confidence.
Generex Biotechnology Corp. (GNBT) Stock Research Links